Novo Nordisk A/S
Long
업데이트됨

$NVO expected have better second half (H2)

1 087
- Potential Inverse H&S on daily?
- In the worst case, NVO goes to 200 monthly moving average around $36
- Nonetheless, We are bottoming fundamentally only question is how fast the turn around gonna be.
노트
- I had a very big position starting this year and but sold pre-earning when they unprofessionally released earnings on breakeven.

- I have bought back around 43.xx but not gonna build a massive position this time because I am afraid that turn around might be slower.
노트
- There are blood in the streets so I want to build bigger position in other companies where turn around could be faster. However, I am buying NVO for long term as weightloss and well being is multi year secular trend
노트
- NVO will still have better second half where it recovers.
- However, it's clear LLY is a superior drug and NVO latest results confirm it
거래청산: 스탑 닿음
노트
pre-market $42 ; I believe this is heading to 200 day monthly moving average around $36 and then might find support or bottom based on fundamentals
노트
pre-market $42 ; I believe this is heading to 200 day monthly moving average around $36 and then might find support or bottom based on fundamentals
노트
NVO as I mentioned probably has bottomed around 200 day monthly average around 35-36 bucks

면책사항

해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.